NCT04316975View on ClinicalTrials.gov

Utility Of Mutational Load As A Predictor For Endoscopic Treatment Response In Barrett's Esophagus

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

April 10, 2020

Primary Completion Date

December 20, 2023

Study Completion Date

December 20, 2023

Conditions
Barretts Esophagus With DysplasiaIntramucosal Adenocarcinoma
Interventions
OTHER

Study Driven Procurement of Biopsies

Four research biopsies collected at the midpoint of current BE or IMC at Baseline and after reaching CEIM. Biopsies will be used to calculate ML scores both pre and post EET.

Trial Locations (1)

27599

University of North Carolina at Chapel Hill, Chapel Hill

Sponsors
All Listed Sponsors
collaborator

Interpace Diagnostics Corporation

UNKNOWN

lead

University of North Carolina, Chapel Hill

OTHER